Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 16;11(6):1727.
doi: 10.3390/biomedicines11061727.

Current State and Prospectives for Proton Boron Capture Therapy

Affiliations
Review

Current State and Prospectives for Proton Boron Capture Therapy

Nhan Hau Tran et al. Biomedicines. .

Abstract

The development of new methods increasing the biological effectiveness of proton therapy (PT) is of high interest in radiation oncology. The use of binary technologies, in which the damaging effect of proton radiation is further enhanced by the selective accumulation of the radiosensitizer in the target tissue, can significantly increase the effectiveness of radiation therapy. To increase the absorbed dose in a tumor target, proton boron capture therapy (PBCT) was proposed based on the reaction of proton capture on the 11B isotope with the formation of three α-particles. This review summarizes data on theoretical and experimental studies on the effectiveness and prospects of proton boron capture therapy.

Keywords: proton boron capture therapy; proton therapy; radiotherapy; sensitization.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no conflict of interest.

Figures

Figure 1
Figure 1
A sketch for PBCT. The dose in the tumor is enhanced by both proton beam targeting at the Bragg peak area (marked by red square) and cell targeting (increased uptake is denoted in green).

References

    1. Gordon K., Gulidov I., Fatkhudinov T., Koryakin S., Kaprin A. Fast and Furious: Fast Neutron Therapy in Cancer Treatment. Int. J. Part. Ther. 2022;9:59–69. doi: 10.14338/IJPT-22-00017. - DOI - PMC - PubMed
    1. Ryzhikova O.A. Proton and hadron therapy in the treatment of oncological diseases. Oncosurgery. 2011;3:89.
    1. Baumann M., Krause M., Overgaard J., Debus J., Bentzen S.M., Daartz J., Richter C., Zips D., Bortfeld T. Radiation oncology in the era of precision medicine. Nat. Rev. Cancer. 2016;16:234–249. doi: 10.1038/nrc.2016.18. - DOI - PubMed
    1. Durante M., Orecchia R., Loeffler J.S. Charged-particle therapy in cancer: Clinical uses and future perspectives. Nat. Rev. Clin. Oncol. 2017;14:483–495. doi: 10.1038/nrclinonc.2017.30. - DOI - PubMed
    1. Mohan R. A review of proton therapy—Current status and future directions. Precis. Radiat. Oncol. 2022;6:164–176. doi: 10.1002/pro6.1149. - DOI - PMC - PubMed

LinkOut - more resources